|
|
||||||||
Neuroradiology |
1 From the Departments of Radiology (Y.M., R.I.G., J.K.U., L.W., L.J.M.) and Neurology (D.L.K.), Hospital of the University of Pennsylvania, Ground Fl, Founders, 3400 Spruce St, Philadelphia, PA 19104-4283; the Division of Biometrics, Hahnemann University, Philadelphia, Pa (M.P.); and the Department of Nuclear Medicine and Diagnostic Imaging, Kyoto University Hospital, Kyoto, Japan (Y.M.). Received June 1, 1998; revision requested July 22; final revision received January 8, 1999; accepted April 22. Supported in part by grants R01 NS29029 and M01-RR00040 from the National Institutes of Health, and grant RG2109B from the National Multiple Sclerosis Society. Address reprint requests to R.I.G. (e-mail: grossman@oasis .rad.upenn.edu).
PURPOSE: To determine the relationship between T2 lesion volume and either disability measurements or change in T2 lesion volume over time in multiple sclerosis (MS).
MATERIALS AND METHODS: Eighteen patients (age range, 2653 years) with clinically proved relapsing-remitting MS were examined every 6 months for over 2 years. Three-millimeter-thick contiguous images of the whole brain were obtained. T2 lesion volume was calculated with a highly reproducible volumetric computer method.
RESULTS: A substantial annual increase in T2 lesion volume, with a median annual increase of approximately 8%, was demonstrated. However, there was no significant correlation between absolute T2 lesion volume and either the absolute expanded disability status scale (EDSS) grade (P = .32) or the absolute ambulation index (AI) (P = .20). In addition, no significant correlation between change in T2 lesion volume and change in EDSS grade (P = .42) or AI (P = .37) was found. There was no significant correlation between T2 lesion volume and duration of disease (P = .08).
CONCLUSION: There is no significant correlation between T2 lesion volume and standardized disability measurements despite a substantial increase in T2 lesion volume over time. Patients have an increase in total T2 lesion volume in the brain regardless of their clinical status or disability measurements. T2 lesion volumes as outcomes in therapeutic clinical trials on MS should be viewed as secondary outcomes rather than as surrogate markers of clinical responses.
Index terms: Brain, diseases, 10.871 Brain, MR, 18.121416 Magnetic resonance (MR), volume measurement, 10.121416 Sclerosis, multiple, 10.871
This article has been cited by other articles:
![]() |
M. Daumer, A. Neuhaus, S. Morrissey, R. Hintzen, and G. C. Ebers MRI as an outcome in multiple sclerosis clinical trials Neurology, February 24, 2009; 72(8): 705 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C. Otaduy, D Callegaro, L A Bacheschi, and C C Leite Correlation of magnetization transfer and diffusion magnetic resonance imaging in multiple sclerosis Multiple Sclerosis, November 1, 2006; 12(6): 754 - 759. [Abstract] [PDF] |
||||
![]() |
D.K.B. Li, U. Held, J. Petkau, M. Daumer, F. Barkhof, F. Fazekas, J. A. Frank, L. Kappos, D. H. Miller, J. H. Simon, et al. MRI T2 lesion burden in multiple sclerosis: A plateauing relationship with clinical disability Neurology, May 9, 2006; 66(9): 1384 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Ranjeva, B. Audoin, M. Van Au Duong, D. Ibarrola, S. Confort-Gouny, I. Malikova, E. Soulier, P. Viout, A. Ali-Cherif, J. Pelletier, et al. Local Tissue Damage Assessed with Statistical Mapping Analysis of Brain Magnetization Transfer Ratio: Relationship with Functional Status of Patients in the Earliest Stage of Multiple Sclerosis AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, R. I. Grossman, J. S. Babb, J. He, and L. J. Mannon Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1935 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S.Y. Li, J. Regal, B. J. Soher, L. J. Mannon, R. I. Grossman, and O. Gonen Brain Metabolite Profiles of T1-Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis AJNR Am. J. Neuroradiol., January 1, 2003; 24(1): 68 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gonen, D. M. Moriarty, B. S. Y. Li, J. S. Babb, J. He, J. Listerud, D. Jacobs, C. E. Markowitz, and R. I. Grossman Relapsing-remitting Multiple Sclerosis and Whole-Brain N-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations Radiology, October 1, 2002; 225(1): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bonneville, D. M. Moriarty, B. S.Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen Whole-Brain N-Acetylaspartate Concentration: Correlation with T2-Weighted Lesion Volume and Expanded Disability Status Scale Score in Cases of Relapsing-Remitting Multiple Sclerosis AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 371 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zivadinov, R. A. Rudick, R. De Masi, D. Nasuelli, M. Ukmar, R. S. Pozzi-Mucelli, A. Grop, G. Cazzato, and M. Zorzon Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS Neurology, October 9, 2001; 57(7): 1239 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Morton, K. R. Maravilla, J. R. Meno, and H. R. Winn Clinically Relevant Rat Model for Testing BOLD Functional MR Imaging Techniques by Using Single-Shot Echo-planar Imaging at 1.5 T Radiology, February 1, 2001; 218(2): 598 - 601. [Abstract] [Full Text] |
||||
![]() |
G. Sinson, L. J. Bagley, K. M. Cecil, M. Torchia, J. C. McGowan, R. E. Lenkinski, T. K. McIntosh, and R. I. Grossman Magnetization Transfer Imaging and Proton MR Spectroscopy in the Evaluation of Axonal Injury: Correlation with Clinical Outcome after Traumatic Brain Injury AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Nusbaum, D. Lu, C. Y. Tang, and S. W. Atlas Quantitative Diffusion Measurements in Focal Multiple Sclerosis Lesions: Correlations with Appearance on TI-Weighted MR Images Am. J. Roentgenol., September 1, 2000; 175(3): 821 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, R. I. Grossman, J. K. Udupa, L. Wei, L. J. Mannon, M. Polansky, and D. L. Kolson Brain Atrophy in Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis: Longitudinal Quantitative Analysis Radiology, March 1, 2000; 214(3): 665 - 670. [Abstract] [Full Text] |
||||